Angiographic evidence of progressive lumen narrowing over 2 years following drug-eluting stent implantation

International Journal of Cardiology

Volumn 153, Issue 2, 2011, Pages 159-164

  Park, Seung Jung ^a   Kim, Young Hak ^a   Kim, Won Jang ^a   Ahn, Jung Min ^a   Yun, Sung Cheol ^a   Lee, Jong Young ^a   Park, Duk Woo ^a   Kang, Soo Jin ^a   Lee, Seung Whan ^a   Lee, Cheol Whan ^a   Park, Seong Wook ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Paclitaxel; Prognosis; Restenosis; Sirolimus; Stent

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE DURATION; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTENOSIS; REVASCULARIZATION; VEIN DIAMETER; VEIN OCCLUSION;

AGED; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; DISEASE PROGRESSION; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 81755164674     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.08.032     Document Type: Article

References (23)

1. M. Joner, G. Nakazawa, and A.V. Finn Endothelial cell recovery between comparatorpolymer-based drug-eluting stents J Am Coll Cardiol 52 2008 333 342
2. A.J. Carter, M. Aggarwal, and G.A. Kopia Long-term effects of polymer-based, slow-release, sirolimus-eluting stents in a porcine coronary model Cardiovasc Res 63 2004 617 624
3. F. Liistro, G. Stankovic, and C. Di Mario First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome Circulation 105 2002 1883 1886
4. R. Waksman, A.E. Ajani, and R.L. White Five-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis Circulation 109 2004 340 344
5. R. Wessely, A. Kastrati, and A. Schomig Late restenosis in patients receiving a polymer-coated sirolimus-eluting stent Ann Intern Med 143 2005 392 394
6. J.J. Popma, M.B. Leon, and J.W. Moses Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries Circulation 110 2004 3773 3780
7. R. Mehran, G. Dangas, and A.S. Abizaid Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome Circulation 100 1999 1872 1878
8. T. Kimura, H. Yokoi, and Y. Nakagawa Three-year follow-up after implantation of metallic coronary-artery stents N Engl J Med 334 1996 561 566
9. M.K. Hong, C.W. Lee, and Y.H. Kim Two-year follow-up intravascular ultrasound analysis after bare metal stent implantation in 120 lesions Catheter Cardiovasc Interv 65 2005 247 253
10. M. Awata, J. Kotani, and M. Uematsu Serial angioscopic evidence of incomplete neointimal coverage after sirolimus-eluting stent implantation: comparison with bare-metal stents Circulation 116 2007 910 916
11. R. Virmani, F. Liistro, and G. Stankovic Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans Circulation 106 2002 2649 2651
12. J.E. Sousa, M.A. Costa, and A. Abizaid Four-year angiographic and intravascular ultrasound follow-up of patients treated with sirolimus-eluting stents Circulation 111 2005 2326 2329
13. C. Spaulding, J. Daemen, and E. Boersma A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents N Engl J Med 356 2007 989 997
14. M. Morice, P.W. Serruys, and P. Barragan Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial J Am Coll Cardiol 50 2007 1299 1304
15. S.J. Kang, D.W. Park, and G.S. Mintz Long-term vascular changes after drug-eluting stent implantation assessed by serial volumetric intravascular ultrasound analysis Am J Cardiol 105 2010 1402 1408
16. M.K. Hong, G.S. Mintz, and C.W. Lee Intravascular ultrasound assessment of patterns of arterial remodeling in the absence of significant reference segment plaque burden in patients with coronary artery disease J Am Coll Cardiol 42 2003 806 810
17. S.J. Pocock, A.J. Lansky, and R. Mehran Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials J Am Coll Cardiol 51 2008 23 32
18. R. Moreno, C. Fernandez, and A. Sanchez-Recalde Clinical impact of in-stent late loss after drug-eluting coronary stent implantation Eur Heart J 28 2007 1583 1591
19. C.W. Lee, K.H. Park, and Y.H. Kim Clinical and Angiographic outcomes after placement of multiple overlapping drug-eluting stents in diffuse coronary lesions Am J Cardiol 98 2006 918 922
20. P.W. Serruys for SPIRIT II investigators SPIRIT II Study: a clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions J Am Coll Cardiol 51 Suppl 1 2008 A261
21. G.C. Meireles, P.A. Lemos, and J.A. Ambrose Luminal recovery from six to twelve months after implantation of "thicker strut" coronary stents Am J Cardiol 93 2004 210 213
22. G.W. Stone, M. Midei, and W. Newman Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial JAMA 299 2008 1903 1913
23. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150